Figure 1.
TET2 gene mutation classification, type, and clinical characteristics. (A) Scatterplot of the VAFs of patients with TET2MT. The VAF of first-hit TET2MT was plotted on the x-axis and that of the second-hit TET2MT, if present, on the y-axis. Patients were categorized into 5 groups as explained in the text. The red oval corresponds to biTET2MT cases, the gray bar to undetermined cases, the blue oval to biclonal TET2MT cases, the light green oval to monoTET2MT cases, and the yellow oval to hemihomozygous TET2MT (UPD) cases. (B) Percentages of different types of TET2MT in biTET2i cases and significance of truncating mutations vs monoTET2MT. Fisher’s exact test was used for analysis. (C) Bar graphs showing the distribution of biTET2i and monoTET2MT cases per diagnosis and cytogenetics. The bar columns indicate percentages. (D) Pie chart showing the percentage of cases per configuration. (E) Pie charts of biTET2i, monoTET2MT, and TET2WT respectively representing the percentage of cases per classification. CMML (+) indicates cases with CMML at the time of presentation, CMML (−) indicates no CMML diagnosis, monocytosis (+) indicates the presence of monocytosis, and monocytosis (−) indicates the absence of monocytosis.

TET2 gene mutation classification, type, and clinical characteristics. (A) Scatterplot of the VAFs of patients with TET2MT. The VAF of first-hit TET2MT was plotted on the x-axis and that of the second-hit TET2MT, if present, on the y-axis. Patients were categorized into 5 groups as explained in the text. The red oval corresponds to biTET2MT cases, the gray bar to undetermined cases, the blue oval to biclonal TET2MT cases, the light green oval to monoTET2MT cases, and the yellow oval to hemihomozygous TET2MT (UPD) cases. (B) Percentages of different types of TET2MT in biTET2i cases and significance of truncating mutations vs monoTET2MT. Fisher’s exact test was used for analysis. (C) Bar graphs showing the distribution of biTET2i and monoTET2MT cases per diagnosis and cytogenetics. The bar columns indicate percentages. (D) Pie chart showing the percentage of cases per configuration. (E) Pie charts of biTET2i, monoTET2MT, and TET2WT respectively representing the percentage of cases per classification. CMML (+) indicates cases with CMML at the time of presentation, CMML (−) indicates no CMML diagnosis, monocytosis (+) indicates the presence of monocytosis, and monocytosis (−) indicates the absence of monocytosis.

Close Modal

or Create an Account

Close Modal
Close Modal